# Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia

> **NCT05574036** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Tanta University** · enrollment: 70 (estimated)

## Conditions studied

- Non Alcoholic Steatohepatitis
- Hyperuricemia

## Interventions

- **DRUG:** Febuxostat 80 MG Oral Tablet
- **DRUG:** vit E

## Key facts

- **NCT ID:** NCT05574036
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-08-25
- **Primary completion:** 2026-05-30
- **Final completion:** 2026-12-25
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05574036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05574036, "Comparative Study Between Febuxostat Versus Vitamin E in Non-alcoholic Steatohepatitis Patients With Hyperuricemia". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05574036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*